Delivery Order SPE2DB20D1100-SPE2DB24FA8L3
Award Date 3/20/24
Potential Completion Date 3/21/24
Potential Value $1.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,260.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,399.22 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $17,666.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The delivery order was issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,844.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM pharmaceuticals. This delivery order was issued under an existing indefinite delivery contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,279.17 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ADVAIR HFA 45-21 MCG INHALER 12GM. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,410.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 230-21 MCG INHALER 12GM. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as the prime contractor. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The $2,979.17 delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,473.06 firm fixed price delivery order to provide ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,325.24 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,256.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA8L3Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a 12GM ADVAIR HFA 115-21 MCG INHALER valued at $1,561.98. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide in support of the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and its parent company is Cencora, Inc.
Generated 6/19/24, 9:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/20/24 |